Asset Details
Do you wish to reserve the book?
Neurofilament light chain as a potential biomarker of perioperative neurocognitive disorders: a systematic review and meta-analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Neurofilament light chain as a potential biomarker of perioperative neurocognitive disorders: a systematic review and meta-analysis
Do you wish to request the book?
Neurofilament light chain as a potential biomarker of perioperative neurocognitive disorders: a systematic review and meta-analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Neurofilament light chain as a potential biomarker of perioperative neurocognitive disorders: a systematic review and meta-analysis
2026
Overview
ObjectivesAlthough neurofilament light chain (NfL) is used as a biomarker of neurodegenerative decline, its application in surgery- and anaesthesia-induced acute cognitive dysfunction remains uncertain. We aimed to synthesise existing evidence to evaluate the potential of NfL as a biomarker for perioperative neurocognitive disorder (PND).DesignSystematic review and meta-analysis.Data sourcesPubMed, EMBASE, MEDLINE, the Cochrane Library and the Cochrane Central Register of Clinical Trials were systematically searched up to March 2024.Eligibility criteriaObservational studies—including cohort, case-control and cross-sectional designs—were included if they reported cerebrospinal fluid (CSF) or blood NfL levels in individuals with and without PND.Data extraction and synthesisThree independent reviewers assessed each article. Quality scoring was conducted, and the extracted data were analysed using STATA. Risk of bias was evaluated using the Newcastle–Ottawa Scale. Meta-analytical model selection was guided by the I2 statistic, with I2≤40% indicating low heterogeneity and the use of a fixed-effect model; random-effects models were used when this threshold was exceeded.ResultsWithin-group analyses showed significant postoperative increases in blood NfL levels in both the postoperative delirium (POD) group (standardised mean difference (SMD) = 0.49; 95% CI 0.34 to 0.64) and the no-POD group (SMD=0.67, 95% CI 0.53 to 0.81). Between-group comparisons revealed significantly higher preoperative CSF NfL levels in the POD group (SMD=0.27, 95% CI 0.07 to 0.47). Both preoperative and postoperative blood NfL levels were also significantly elevated in the POD group (SMD=0.53, 95% CI 0.40 to 0.66, and SMD=0.58, 95% CI 0.43 to 0.73, respectively).ConclusionsThis meta-analysis suggests that NfL may be a potential biomarker for POD. Further research is needed to clarify the association between CSF and blood NfL levels and other forms of PND.PROSPERO registration numberCRD42024516907.
Publisher
British Medical Journal Publishing Group,BMJ Publishing Group LTD,BMJ Publishing Group
Subject
/ Biomarkers - cerebrospinal fluid
/ Delirium
/ Humans
/ Light
/ Medical Subject Headings-MeSH
/ Neurocognitive Disorders - blood
/ Neurocognitive Disorders - cerebrospinal fluid
/ Neurocognitive Disorders - diagnosis
/ Neurofilament Proteins - blood
/ Neurofilament Proteins - cerebrospinal fluid
/ Proteins
/ SURGERY
